ALK(SZ:002940) Ge Long Hui A P P·2025-08-03 08:05Group 1 - The stock of Zhejiang Anglikang Pharmaceutical Co., Ltd. (stock code: 002940) experienced an abnormal price fluctuation, with a cumulative closing price deviation exceeding 20% over two consecutive trading days (July 31, 2025, and August 1, 2025) [1] - The company's board of directors conducted an investigation and confirmed that there were no undisclosed significant matters affecting the stock price, and the company's operational status remains normal [1][2] - The company has one innovative drug project, ALK-N001, which is currently in Phase I clinical trials, and is aware of investor interest in another project, ALK-N002, which is still in the candidate selection phase [2] Group 2 - The innovative drug development and investment are characterized by long cycles, high investment, and significant uncertainty, which investors should be aware of [2]